跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,590 条关于
“Grünenthal Group”
全部
26,590
临床试验
18,013
药物
560
机构
509
资讯
7,508
5年前
Grünenthal Leaders Outline Four Key Principles for Future Pharmaceutical Marketing in Post-COVID Era
2个月前
Grünenthal Joins Munich Nucleic Acid Therapeutics Cluster to Advance Oligonucleotide-Based Pain and Neurology Pipeline
去年
Phase III Trial of Qutenza® for Post-Surgical Neuropathic Pain Completes Enrollment
7个月前
Grünenthal Initiates Phase I Trial of Novel NaV 1.8 Inhibitor for Non-Opioid Pain Management
去年
Resiniferatoxin Receives FDA Breakthrough Therapy Designation for Osteoarthritis Pain
去年
Grünenthal Completes Enrollment for Phase III Trial of Qutenza in Post-Surgical Neuropathic Pain
去年
Grünenthal Initiates Phase I Trial of Nociceptin Receptor Agonist for Chronic Pain
3个月前
Grünenthal Completes Phase I Trial for First-in-Class NOP Agonist, Plans Phase II in Acute Pain
去年
Qutenza Phase III Trial Completes Recruitment for Post-Surgical Neuropathic Pain
去年
Qutenza Phase III Trial Completes Recruitment for Post-Surgical Neuropathic Pain
第 1 页,共 751 页
上一页
下一页